Completed PHASE4 INTERVENTIONAL 3-arm NCT01651416

Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana

An Individually Randomised Trial of Seasonal Malaria Chemoprevention Versus a Long-acting Artemisinin Combination Therapy for the Prevention of Malaria and Anaemia in Children Living in an Area of Extended Seasonal Transmission in Ghana.

Sponsor: Centre for Global Health Research, Ghana

Conditions Anaemia Malaria

Interventions Amodiaquine plus sulphadoxine-pyrimethamine combination Artemether-lumefantrine combination Dihydroartemisinin Piperaquine combination

Updated 5 times since 2017 Last updated: Sep 17, 2015 Started: Jul 31, 2012 Primary completion: Dec 31, 2012 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Anaemia and Malaria and is currently completed. Centre for Global Health Research, Ghana leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre for Global Health Research, Ghana
London School of Hygiene and Tropical Medicine

Data source: Centre for Global Health Research, Ghana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kumasi, Ghana